From: TH1 cytokine response to HCV peptides in Egyptian health care workers: a pilot study
Group | INFγ & IL2 | IL2 & TNFα | TNFα & INFγ | ||||||
---|---|---|---|---|---|---|---|---|---|
HCV Peptide | Rs | p | HCV Peptide | Rs | p | HCV Peptide | Rs | p | |
1- a:Positive P.I HCWs: | Core | 0.514 | 0.014 | Core | 0.279 | 0.21 | Core | 0.447 | 0.028 |
NS3 | 0.51 | 0.024 | NS3 | −0.1 | 0.6 | NS3 | 0.2 | 0.3 | |
NS4 | 0.226 | 0.311 | NS4 | 0.797 | 0.44 | NS4 | 0.436 | 0.026 | |
NS5 | 0.512 | 0.015 | NS5 | 0.127 | 0.60 | NS5 | 0.445 | 0.03 | |
1-b: Negative P.I HCWs: | Core | 0.403 | 0.282 | Core | −0.53 | 0.14 | Core | −0.153 | 0.694 |
NS3 | 0.451 | 0.223 | NS3 | −0.6 | 0.1 | NS3 | −0.5 | 0.1 | |
NS4 | 0.893 | 0.003 | NS4 | 0.47 | 0.24 | NS4 | −0.035 | 0.924 | |
NS5 | 0.72 | 0.029 | NS5 | 0.644 | 0.06 | NS5 | 0.338 | 0.339 | |
2-Chronic HCV HCW | Core | −0.395 | 0.439 | Core | −0.6 | 0.28 | Core | −0.112 | 0.858 |
NS3 | −0.894 | 0.041 | NS3 | −0.1 | 0.8 | NS3 | 0.8 | 0.04 | |
NS4 | 0.051 | 0.935 | NS4 | 0.60 | 0.285 | NS4 | 0.698 | 0.123 | |
NS5 | −0.213 | 0.686 | NS5 | −0.5 | 0.391 | NS5 | 0.759 | 0.08 |